Literature DB >> 28620818

Effects of atorvastatin and simvastatin on oxidative stress in diet-induced hyperhomocysteinemia in Wistar albino rats: a comparative study.

T Nikolic1, V Zivkovic2, I Srejovic2, I Stojic1, N Jeremic1, J Jeremic1, K Radonjic1, S Stankovic3, R Obrenovic3, D Djuric4, V Jakovljevic5,6.   

Abstract

Considering the well-known antioxidant properties of statins, it seems important to assess their impact on major markers of oxidative stress (superoxide anion radical, nitric oxide, and index of lipid peroxidation) to compare the antioxidative potentials of atorvastatin and simvastatin during the different degrees of hyperhomocysteinemia (HHcy) in rats. This study was conducted on adult male Wistar albino rats (n = 90; 4 weeks old; 100 ± 15 g body mass) in which HHcy was achieved by dietary manipulation. For 4 weeks, the animals were fed with one of the following diets: standard rodent chow, diet enriched in methionine with no deficiency in B vitamins (folic acid, B6, and B12), or diet enriched in methionine and deficient in B vitamins (folic acid, B6, and B12). At the same time, animals were treated with atorvastatin at doses of 3 mg/kg/day i.p. or simvastatin at doses of 5 mg/kg/day i.p. Levels of superoxide anion radical and TBARS were significantly decreased by administration of simvastatin in normal and high-homocysteine (Hcy) groups (p < 0.05). At 4 weeks after feeding with purified diets, the concentrations of the GSH, CAT, and SOD antioxidants were significantly affected among all groups (p < 0.05). Our results indicated that statin therapy had variable effects on the redox status in hyperhomocysteinemic rats, and simvastatin demonstrated stronger antioxidant effects than did atorvastatin.

Entities:  

Keywords:  Hyperhomocysteinemia; Oxidative stress; Rat; Statins

Mesh:

Substances:

Year:  2017        PMID: 28620818     DOI: 10.1007/s11010-017-3099-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

2.  The oxidant stress of hyperhomocyst(e)inemia.

Authors:  J Loscalzo
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Oxidative stress and inflammation are differentially affected by atorvastatin, pravastatin, rosuvastatin, and simvastatin on lungs from mice exposed to cigarette smoke.

Authors:  Thiago Santos Ferreira; Manuella Lanzetti; Marina Valente Barroso; Carlos Romualdo Rueff-Barroso; Cláudia Farias Benjamim; Lycia de Brito-Gitirana; Luís Cristóvão Porto; Samuel Santos Valença
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 4.  Cardiovascular disease in the literature: A selection of recent original research papers.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-12-09       Impact factor: 5.952

Review 5.  Pharmacogenomics knowledge for personalized medicine.

Authors:  M Whirl-Carrillo; E M McDonagh; J M Hebert; L Gong; K Sangkuhl; C F Thorn; R B Altman; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2012-10       Impact factor: 6.875

6.  Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: Biochemical, morphological and histological studies.

Authors:  Bhavesh C Variya; Snehal S Patel; Jinal I Trivedi; Hardik P Gandhi; S P Rathod
Journal:  Eur J Pharmacol       Date:  2015-07-10       Impact factor: 4.432

Review 7.  Homocysteine and the pathogenesis of atherosclerosis.

Authors:  Kilmer S McCully
Journal:  Expert Rev Clin Pharmacol       Date:  2015-02-05       Impact factor: 5.045

Review 8.  Statins and oxidative stress in chronic heart failure.

Authors:  Sónia Costa; Marta Reina-Couto; António Albino-Teixeira; Teresa Sousa
Journal:  Rev Port Cardiol       Date:  2016-01-04       Impact factor: 1.374

9.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

Review 10.  Role of homocysteine in the development of cardiovascular disease.

Authors:  Paul Ganguly; Sreyoshi Fatima Alam
Journal:  Nutr J       Date:  2015-01-10       Impact factor: 3.271

View more
  4 in total

1.  Nuclear factor erythroid 2-related factor 2 activation mediates hyperhomocysteinemia-associated lipolysis suppression in adipocytes.

Authors:  Xin Li; Yuhong Cheng; Xiuli Zhong; Bing Zhang; Zhiwei Bao; Yi Zhang; Zhigang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2018-07

Review 2.  Cerebral Small Vessel Disease (CSVD) - Lessons From the Animal Models.

Authors:  Muzaimi Mustapha; Che Mohd Nasril Che Mohd Nassir; Niferiti Aminuddin; Amanina Ahmad Safri; Mazira Mohamad Ghazali
Journal:  Front Physiol       Date:  2019-10-24       Impact factor: 4.566

3.  The preventive effect of atorvastatin on liver fibrosis in the bile duct ligation rats via antioxidant activity and down-regulation of Rac1 and NOX1.

Authors:  Zohreh-Al-Sadat Ghoreshi; Razieh Kabirifar; Ameneh Khodarahmi; Alireza Karimollah; Ali Moradi
Journal:  Iran J Basic Med Sci       Date:  2020-01       Impact factor: 2.699

4.  Crataegus Aronia protects and reverses vascular inflammation in a high fat diet rat model by an antioxidant mechanism and modulating serum levels of oxidized low-density lipoprotein.

Authors:  Abdullah S Shatoor; Suliman Al Humayed; Mahmoud A Alkhateeb; Khalid A Shatoor; Hussain Aldera; Mohammed Alassiri; Ali A Shati
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.